Literature DB >> 24302626

Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.

Yujun Gan1, Andrew J Paterson, Yue Zhang, Jing Jiang, Stuart J Frank.   

Abstract

GH signals through the GH receptor (GHR), a cytokine receptor linked to Janus kinase 2 (JAK2). GH activates signal transducer and activator of transcription 5 (STAT5), causing expression of genes including IGF-I. IGF-I binds IGF-I receptor (IGF-IR), a heterotetrameric (α2-β2) tyrosine kinase growth factor receptor similar to insulin receptor (IR). In addition to this GH -> GHR -> IGF-I -> IGF-IR pathway, GH induces a complex including GHR, JAK2, and IGF-IR and deletion of floxed IGF-1R in primary murine calvarial cells with Cre-recombinase-expressing adenovirus (Ad-Cre) desensitizes cells to GH for STAT5 activation and IGF-I mRNA accumulation. Diminished GH-induced STAT5 phosphorylation in Ad-Cre-treated cells is rescued by adenoviruses encoding either IGF-IR or IGF-IR lacking the β-chain intracellular domain. Reasoning that IGF-IR's extracellular portion (α or extracellular β) mediates functional interaction with GH signaling, we pursued reconstitution studies. Although structurally related to IGF-IR, IR expressed adenovirally did not rescue GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. We thus created chimeras, swapping homologous IR extracellular regions into IGF-IR. IR and IGF-IR possess N-terminal L1, cysteine-rich (CR), and L2 α-chain domains. We created Ad-IGF-IR/IR-L1 and Ad-IGF-IR/IR-L1-CR-L2, in which L1 alone or L1, CR, and L2 of IR replace corresponding IGF-IR regions, respectively. Ad-IGF-IR/IR-L1, but not Ad-IGF-IR/IR-L1-CR-L2, rescued GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. Additionally, medium containing a soluble IGF-IR (including only L1-CR-L2) dampened GH-induced STAT5 phosphorylation in calvarial cells and two other GH-responsive cell lines. Thus, an extracellular determinant(s), likely in CR-L2, specifically allows IGF-IR to collaborate with GHR and JAK2 for robust GH-induced acute STAT5 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24302626      PMCID: PMC3929739          DOI: 10.1210/en.2013-1732

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  45 in total

Review 1.  Investigation protocol: acromegaly and its investigation.

Authors:  E Duncan; J A Wass
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

2.  A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.

Authors:  W D SALMON; W H DAUGHADAY
Journal:  J Lab Clin Med       Date:  1957-06

Review 3.  Signaling pathways activated by the growth hormone receptor.

Authors:  J Herrington; C Carter-Su
Journal:  Trends Endocrinol Metab       Date:  2001-08       Impact factor: 12.015

4.  Structure of the insulin receptor ectodomain reveals a folded-over conformation.

Authors:  Neil M McKern; Michael C Lawrence; Victor A Streltsov; Mei-Zhen Lou; Timothy E Adams; George O Lovrecz; Thomas C Elleman; Kim M Richards; John D Bentley; Patricia A Pilling; Peter A Hoyne; Kellie A Cartledge; Tam M Pham; Jennifer L Lewis; Sonia E Sankovich; Violet Stoichevska; Elizabeth Da Silva; Christine P Robinson; Maurice J Frenkel; Lindsay G Sparrow; Ross T Fernley; V Chandana Epa; Colin W Ward
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

5.  The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity.

Authors:  Meizhen Lou; Thomas P J Garrett; Neil M McKern; Peter A Hoyne; V Chandana Epa; John D Bentley; George O Lovrecz; Leah J Cosgrove; Maurice J Frenkel; Colin W Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

6.  In vivo imaging of hepatic growth hormone signaling.

Authors:  Stuart J Frank; Xiangdong Wang; Kai He; Ning Yang; Peng Fang; Ron G Rosenfeld; Vivian Hwa; Tandra R Chaudhuri; Luqin Deng; Kurt R Zinn
Journal:  Mol Endocrinol       Date:  2006-06-27

7.  Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse.

Authors:  Zhuohua Wang; Gail S Prins; Karen T Coschigano; John J Kopchick; Jeffrey E Green; Vera H Ray; Samad Hedayat; Konstantin T Christov; Terry G Unterman; Steven M Swanson
Journal:  Endocrinology       Date:  2005-09-01       Impact factor: 4.736

Review 8.  The insulin and EGF receptor structures: new insights into ligand-induced receptor activation.

Authors:  Colin W Ward; Michael C Lawrence; Victor A Streltsov; Timothy E Adams; Neil M McKern
Journal:  Trends Biochem Sci       Date:  2007-02-05       Impact factor: 13.807

9.  Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor.

Authors:  T P Garrett; N M McKern; M Lou; M J Frenkel; J D Bentley; G O Lovrecz; T C Elleman; L J Cosgrove; C W Ward
Journal:  Nature       Date:  1998-07-23       Impact factor: 49.962

Review 10.  New insights into growth hormone action.

Authors:  M J Waters; H N Hoang; D P Fairlie; R A Pelekanos; R J Brown
Journal:  J Mol Endocrinol       Date:  2006-02       Impact factor: 5.098

View more
  6 in total

1.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

2.  DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH.

Authors:  Zhongbo Liu; Oran D Kennedy; Luis Cardoso; Jelena Basta-Pljakic; Nicola C Partridge; Mitchell B Schaffler; Clifford J Rosen; Shoshana Yakar
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

Review 3.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

4.  Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.

Authors:  Yujun Gan; Ashiya Buckels; Ying Liu; Yue Zhang; Andrew J Paterson; Jing Jiang; Kurt R Zinn; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2014-09-11

5.  Bone Status in a Patient with Insulin-Like Growth Factor-1 Receptor Deletion Syndrome: Bone Quality and Structure Evaluation Using Dual-Energy X-Ray Absorptiometry, Peripheral Quantitative Computed Tomography, and Quantitative Ultrasonography.

Authors:  Paola Pelosi; Elisabetta Lapi; Loredana Cavalli; Alberto Verrotti; Marilena Pantaleo; Maurizio de Martino; Stefano Stagi
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-05       Impact factor: 5.555

Review 6.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.